Evidence map

ArticlePediatric nephrology (Berlin, Germany)2026

Caution in extending SGLT2 inhibitor trials to children with CAKUT: a call for phenotype-specific safety considerations.

Guido Filler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41571840